[go: up one dir, main page]

NO20021948L - Contraceptives based on a progesterone and an estrogen and a process for the preparation thereof - Google Patents

Contraceptives based on a progesterone and an estrogen and a process for the preparation thereof

Info

Publication number
NO20021948L
NO20021948L NO20021948A NO20021948A NO20021948L NO 20021948 L NO20021948 L NO 20021948L NO 20021948 A NO20021948 A NO 20021948A NO 20021948 A NO20021948 A NO 20021948A NO 20021948 L NO20021948 L NO 20021948L
Authority
NO
Norway
Prior art keywords
progesterone
estrogen
preparation
contraceptives
contraceptives based
Prior art date
Application number
NO20021948A
Other languages
Norwegian (no)
Other versions
NO20021948D0 (en
NO330885B1 (en
Inventor
Jacques Paris
Jean-Louis Thomas
Original Assignee
Theramex
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9542725&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20021948(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Theramex filed Critical Theramex
Publication of NO20021948D0 publication Critical patent/NO20021948D0/en
Publication of NO20021948L publication Critical patent/NO20021948L/en
Publication of NO330885B1 publication Critical patent/NO330885B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
NO20021948A 1999-10-25 2002-04-25 Use of a preparation comprising estradiol and nomegestrol acetate for the manufacture of a contraceptive product and a contraceptive product. NO330885B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/FR1999/002587 WO2001030355A1 (en) 1999-10-25 1999-10-25 Contraceptive medicine based on a progestational agent and an oestrogen and preparation method
PCT/FR2000/002952 WO2001030358A1 (en) 1999-10-25 2000-10-24 Contraceptive medicament based on a progesterone and an oestrogen and method for producing the same

Publications (3)

Publication Number Publication Date
NO20021948D0 NO20021948D0 (en) 2002-04-25
NO20021948L true NO20021948L (en) 2002-06-25
NO330885B1 NO330885B1 (en) 2011-08-08

Family

ID=9542725

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20021948A NO330885B1 (en) 1999-10-25 2002-04-25 Use of a preparation comprising estradiol and nomegestrol acetate for the manufacture of a contraceptive product and a contraceptive product.

Country Status (21)

Country Link
EP (2) EP2020236B1 (en)
JP (1) JP5484646B2 (en)
KR (1) KR100549625B1 (en)
CN (1) CN1205936C (en)
AP (1) AP1707A (en)
AU (1) AU784478B2 (en)
BR (1) BR0014952A (en)
CA (1) CA2388857C (en)
CR (1) CR6627A (en)
CZ (1) CZ301982B6 (en)
ES (1) ES2565688T3 (en)
HK (1) HK1048600A1 (en)
HU (1) HU230467B1 (en)
IL (2) IL149141A0 (en)
MX (1) MXPA02004083A (en)
NO (1) NO330885B1 (en)
NZ (1) NZ518308A (en)
OA (1) OA12071A (en)
RU (1) RU2258512C2 (en)
WO (2) WO2001030355A1 (en)
ZA (1) ZA200203399B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2754179B1 (en) 1996-10-08 1998-12-24 Theramex NOVEL HORMONONAL COMPOSITION AND ITS USE
WO2001030356A1 (en) 1999-10-25 2001-05-03 Laboratoire Theramex Hormonal composition based on a progestational agent and an oestrogen and use thereof
FR2814074B1 (en) * 2000-09-15 2003-03-07 Theramex NOVEL TOPICAL ESTRO-PROGESTIVE COMPOSITIONS WITH SYSTEMIC EFFECT
KR100975350B1 (en) * 2002-11-29 2010-08-12 재단법인서울대학교산학협력재단 Transformed cloned cows producing human lactoferricin and methods for producing the same
AU2005269938A1 (en) * 2004-07-07 2006-02-09 Wyeth Cyclic progestin regimens and kits
AU2006249349B2 (en) * 2005-05-26 2012-01-12 Teva Women's Health, Inc. Oral dosage forms comprising progesterone and methods of making and using the same
CN103877059A (en) * 2014-03-26 2014-06-25 邵娜 Nomegestrol acetate tablet and preparation process thereof

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390531A (en) 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4921843A (en) 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
US4628051A (en) 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
IE61236B1 (en) 1986-07-15 1994-10-19 American Home Prod Combination dosage form for pre-menopausal women
ATE209919T1 (en) 1987-09-24 2001-12-15 Jencap Res Ltd CONTRACEPT PACKS CONTAINING ESTROGEN AND PROGESTIN
IE71203B1 (en) 1990-12-13 1997-02-12 Akzo Nv Low estrogen oral contraceptives
IE62665B1 (en) 1990-12-17 1995-02-22 Akzo Nv Contraceptive regimen
US5532416A (en) 1994-07-20 1996-07-02 Monsanto Company Benzoyl derivatives and synthesis thereof
DE4344462C2 (en) 1993-12-22 1996-02-01 Schering Ag Composition for contraception
FR2737411B1 (en) * 1995-08-01 1997-10-17 Theramex NOVEL HORMONAL DRUGS AND THEIR USE FOR CORRECTING ESTROGENIC DEFICIENCIES
DE19529767A1 (en) 1995-08-12 1997-02-13 Huels Chemische Werke Ag Amphiphilic compounds with several hydrophilic and hydrophobic groups based on amino succinic acid derivatives
US5902914A (en) 1995-08-14 1999-05-11 Alliedsignal Inc. Process for the preparation of halogenated alkanes
AUPN479995A0 (en) 1995-08-15 1995-09-07 Leon Kruss Technology Pty Limited Lightweight cementitious composition
US5654494A (en) 1995-08-18 1997-08-05 Alliedsignal Inc. Process for the manufacture of 1,1,1,2-tetrafluoroethane
US5530167A (en) 1995-08-21 1996-06-25 Eastman Chemical Company Process for the preparation of 1,4-butenediol
DE19536742A1 (en) 1995-10-02 1997-04-03 Teves Gmbh Alfred Wiper blade for a windshield wiper device of a vehicle
DE29515703U1 (en) 1995-10-02 1996-02-08 Föhl, Artur, 73614 Schorndorf Rotary drive device for a belt tensioner
DE19536745A1 (en) 1995-10-02 1997-04-03 Teves Gmbh Alfred Wiper blade for a windshield wiper device of a vehicle, in particular a motor vehicle
DE19536744A1 (en) 1995-10-02 1997-04-03 Teves Gmbh Alfred Wiper blade with interchangeable wiper rubber for a vehicle wiper
JP3616966B2 (en) 1995-10-02 2005-02-02 エヌエスケー・オートリブ株式会社 Seat belt retractor
DE69623901T2 (en) 1995-10-23 2003-01-23 Honda Access Corp., Niiza Head-covering body of a helmet
DE19540253C2 (en) 1995-10-28 1998-06-04 Jenapharm Gmbh Multi-phase preparation for contraception based on natural estrogens
DE19549264A1 (en) 1995-12-23 1997-06-26 Schering Ag Contraception procedure and kit
AU2815897A (en) 1996-05-08 1997-11-26 American Home Products Corporation Oral contraceptive
FR2754179B1 (en) * 1996-10-08 1998-12-24 Theramex NOVEL HORMONONAL COMPOSITION AND ITS USE
GB9621990D0 (en) 1996-10-22 1996-12-18 Scotia Pharma Ltd Use
DE19705229C2 (en) 1997-02-12 1999-04-15 Hesch Rolf Dieter Prof Dr Med Use of three hormonal components for hormonal contraception for the treatment and / or prophylaxis of tumors of the mammary glands
US5898032A (en) * 1997-06-23 1999-04-27 Medical College Of Hampton Roads Ultra low dose oral contraceptives with less menstrual bleeding and sustained efficacy
EP1007052B1 (en) 1997-08-27 2004-10-13 Ortho-McNeil Pharmaceutical, Inc. Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception
DE19739916C2 (en) 1997-09-11 2001-09-13 Hesch Rolf Dieter Use of a combination of a progestogen and an estrogen for the continuous inhibition of ovulation and possibly simultaneous treatment and / or prophylaxis of tumors of the mammary glands
JP2001516720A (en) * 1997-09-12 2001-10-02 アメリカン・ホーム・プロダクツ・コーポレイション Oral contraceptive formulation having progestin / estrogen first phase and progestin second phase

Also Published As

Publication number Publication date
BR0014952A (en) 2003-07-29
HU230467B1 (en) 2016-07-28
HK1129564A1 (en) 2009-12-04
EP2020236B1 (en) 2016-01-27
CA2388857C (en) 2011-06-07
RU2002113654A (en) 2004-01-27
ZA200203399B (en) 2004-02-09
JP5484646B2 (en) 2014-05-07
OA12071A (en) 2006-05-04
CN1205936C (en) 2005-06-15
AU784478B2 (en) 2006-04-13
CR6627A (en) 2008-06-18
CZ301982B6 (en) 2010-08-25
AP1707A (en) 2007-02-26
EP2020236A1 (en) 2009-02-04
PL354518A1 (en) 2004-01-26
HUP0203443A3 (en) 2003-12-29
KR20020073333A (en) 2002-09-23
WO2001030358A1 (en) 2001-05-03
CN1382054A (en) 2002-11-27
NZ518308A (en) 2006-01-27
HUP0203443A2 (en) 2003-01-28
IL149141A0 (en) 2002-11-10
NO20021948D0 (en) 2002-04-25
CZ20021426A3 (en) 2002-08-14
MXPA02004083A (en) 2003-08-20
NO330885B1 (en) 2011-08-08
EP1227815A1 (en) 2002-08-07
HK1048600A1 (en) 2003-04-11
WO2001030355A1 (en) 2001-05-03
KR100549625B1 (en) 2006-02-08
CA2388857A1 (en) 2001-05-03
ES2565688T3 (en) 2016-04-06
AU1033501A (en) 2001-05-08
AP2002002485A0 (en) 2002-06-30
RU2258512C2 (en) 2005-08-20
IL149141A (en) 2008-06-05
JP2003518013A (en) 2003-06-03

Similar Documents

Publication Publication Date Title
AU1176199A (en) Aligner, exposure method and device manufacturing method
AU9648198A (en) Aligner and exposure method
FR2772617B1 (en) PROGESTERONE TABLET AND PROCESS FOR THE PREPARATION THEREOF
AU9095798A (en) Stage device, a scanning aligner and a scanning exposure method, and a device manufactured thereby
SG83821A1 (en) Stage device and exposure apparatus
AU2325900A (en) Exposure device, exposure method, and device manufacturing method
AU3676500A (en) Aligner, microdevice, photomask, exposure method, and method of manufacturing device
AU3325500A (en) Position determining device, position determining method and exposure device, exposure method and alignment determining device, and alignment determining method
SG53076A1 (en) Integrated circuit device and process for its manufacture
DE60026039D1 (en) EXPANDABLE INTRALUMINAL DEVICE
AU1504799A (en) Aligner, exposure method and method of manufacturing device
AU8357398A (en) Exposure method and aligner
AP2002002475A0 (en) Hormonal composition based on a progesterone and an oestrogen and use thereof
NO20021948L (en) Contraceptives based on a progesterone and an estrogen and a process for the preparation thereof
AU8021300A (en) Electronic technical support marketplace system and method
NO971449L (en) New hormonal medications and their use for the correction of estrogen deficiency
AU1307601A (en) Integrated circuit device and correction method for integrated circuit device
AU6270599A (en) Integrated circuit attachment process and apparatus
AU1687999A (en) Exposure method and scanning-type aligner
AU1173499A (en) Exposure method and aligner
AU2002222596A1 (en) Position measuring method, exposure method and system thereof, device productionmethod
DE59508403D1 (en) 14ALPHA, 17ALPHA-C2 BRIDGED 19-NOR PROGESTERONE DERIVATIVES
AU6021800A (en) Exposing method and apparatus
AU1184701A (en) A method and a device for the evacuation of an animal stall
AU2001280175A1 (en) Exposure method and device

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: THERAMEX HQ UK LIMITED, GB

MK1K Patent expired